All lobbying filings
NOVEL STRATEGIES (FKA) PRISM GROUP
NOVEL STRATEGIES (FKA) PRISM GROUP filed a Q2 termination report for GENEVANT SCIENCES, INC. on July 17, 2025, reporting $40,000 in lobbying income.
Lobbying for GENEVANT SCIENCES, INC. · Business/legal/admin.for tech-focused nucleic acid development and delivery company
Filing · LD-2 quarterly report
Q2 termination
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 17, 2025
Income
$40,000
What the client paid this registrant for the period.
Client based in
Massachusetts
Representation ended
May 31, 2025
The registrant reported terminating its work for this client.
Lobbyists on this filing
1
-
JAY BRETT PERRON
Government bodies contacted
2
Lobbying activity
1
Healthcare matters